中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

阻断HBV母婴传播: 热点与难点

尹雪如 洪睿轩 刘志华 侯金林

引用本文:
Citation:

阻断HBV母婴传播: 热点与难点

DOI: 10.12449/JCH241102
基金项目: 

广州市科技基础与应用基础研究专题 (2023A04J2299)

利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:尹雪如、洪睿轩负责文章撰写;刘志华负责文章审核;侯金林负责终审,并最终定稿。
详细信息
    通信作者:

    尹雪如, evonneyin@163.com (ORCID: 0000-0001-9469-9366)

Hotspots and challenges in blocking the mother-to-child transmission of hepatitis B virus

Research funding: 

Science and Technology Projects in Guangzhou (2023A04J2299)

More Information
    Corresponding author: YIN Xueru, evonneyin@163.com (ORCID: 0000-0001-9469-9366)
  • 摘要: 慢性HBV感染是我国最重要的公共卫生问题之一,HBV感染人群超过7 000万,防控工作面临着严峻挑战。当前政府及社会各界正在加速推进“2030年实现消除病毒性肝炎对公众健康的威胁”的宏伟目标。母婴传播是HBV最主要的传播途径,因此,做好HBV母婴阻断是消除病毒性肝炎的关键一环。目前在该领域存在一些热点与难点问题亟需解决,包括妊娠期采用富马酸丙酚替诺福韦长期治疗的安全性、妊娠早期抗病毒治疗的安全性、无免疫球蛋白策略的有效性和HBV经生殖细胞传播的风险等,解决这些问题对进一步推进HBV母婴阻断工作,加快我国实现2030年目标的进程具有重要作用。

     

  • [1] World Health Organization. Global health sector strategy on viral hepatitis 2016-2021[R]. Geneva: World Health Organization, 2016.
    [2] Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: A modelling study[J]. Lancet Gastroenterol Hepatol, 2023, 8( 10): 879- 907. DOI: 10.1016/S2468-1253(23)00197-8.
    [3] LIANG XF, BI SL, YANG WZ, et al. Epidemiological serosurvey of hepatitis B in China: Declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine, 2009, 27( 47): 6550- 6557. DOI: 10.1016/j.vaccine.2009.08.048.
    [4] Infectious Diseases Physicians Branch, Chinese Medical Doctor Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus(version 2024)[J]. J Clin Hepatol, 2024, 40( 8): 1557- 1566. DOI: 10.12449/JCH240809.

    中国医师协会感染科医师分会, 中华医学会感染病学分会. 中国乙型肝炎病毒母婴传播防治指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 8): 1557- 1566. DOI: 10.12449/JCH240809.
    [5] European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection[J]. J Hepatol, 2017, 67( 2): 370- 398. DOI: 10.1016/j.jhep.2017.03.021.
    [6] TERRAULT NA, LOK ASF, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67( 4): 1560- 1599. DOI: 10.1002/hep.29800.
    [7] Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2019)[J]. J Clin Hepatol, 2019, 35( 12): 2648- 2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35( 12): 2648- 2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
    [8] PAN SF, ZHANG Y, ZENG YF, et al. Comparison of the efficacy and safety of TAF, TDF, and LdT to prevent the transmission of hepatitis B in pregnant women: A retrospective study[J]. Immun Inflamm Dis, 2024, 12( 2): e1204. DOI: 10.1002/iid3.1204.
    [9] ZENG QL, YU ZJ, JI F, et al. Tenofovir alafenamide to prevent perinatal hepatitis B transmission: A multicenter, prospective, observational study[J]. Clin Infect Dis, 2021, 73( 9): e3324- e3332. DOI: 10.1093/cid/ciaa1939.
    [10] DING Y, CAO LH, ZHU LY, et al. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: A national cohort study[J]. Aliment Pharmacol Ther, 2020, 52( 8): 1377- 1386. DOI: 10.1111/apt.16043.
    [11] ZENG QL, ZHANG HX, ZHANG JY, et al. Tenofovir alafenamide for pregnant Chinese women with active chronic hepatitis B: A multicenter prospective study[J]. Clin Gastroenterol Hepatol, 2022, 20( 12): 2826- 2837. e 9. DOI: 10.1016/j.cgh.2021.12.012.
    [12] PREBOTH M. The antiretroviral pregnancy registry interim report[J]. Am Fam Physician, 2000, 61( 7): 2265.
    [13] CHEN RC, ZOU J, LONG LY, et al. Safety and efficacy of tenofovir alafenamide fumarate in early-middle pregnancy for mothers with chronic hepatitis B[J]. Front Med(Lausanne), 2022, 8: 796901. DOI: 10.3389/fmed.2021.796901.
    [14] YIN XR, HAN GR, ZHANG H, et al. A real-world prospective study of mother-to-child transmission of HBV in China using a mobile health application(shield 01)[J]. J Clin Transl Hepatol, 2020, 8( 1): 1- 8. DOI: 10.14218/JCTH.2019.00057.
    [15] YIN XR, WANG W, CHEN H, et al. Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China[J]. Nat Med, 2024, 30( 2): 455- 462. DOI: 10.1038/s41591-023-02782-x.
    [16] Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2022)[J]. Chin J Clin Infect Dis, 2022, 15( 6): 401- 427. DOI: 10.3760/cma.j.issn.1674-2397.2022.06.001.

    中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华临床感染病杂志, 2022, 15( 6): 401- 427. DOI: 10.3760/cma.j.issn.1674-2397.2022.06.001.
    [17] World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection[EB/OL].( 2024-03-29)[ 2024-09-21]. https://www.who.int/publications/i/item/9789240090903. https://www.who.int/publications/i/item/9789240090903
    [18] PAN CQ, DAI EH, YANG CL, et al. Tenofovir-df therapy prevents hepatitis B vertical transmission in highly viremic mothers without hbv immunoglobulin for infants[EB/OL].( 2022-10-21). https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.32697. DOI: 10.1002/hep.32697
    [19] SEGERAL O, DIM B, DURIER C, et al. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia(TA-PROHM): A single-arm, multicentre, phase 4 trial[J]. Lancet Infect Dis, 2022, 22( 8): 1181- 1190. DOI: 10.1016/S1473-3099(22)00206-7.
    [20] SMITH K, SPADAFORA C. Sperm-mediated gene transfer: Applications and implications[J]. Bioessays, 2005, 27( 5): 551- 562. DOI: 10.1002/bies.20211.
    [21] SPADAFORA C. Sperm cells and foreign DNA: A controversial relation[J]. Bioessays, 1998, 20( 11): 955- 964. DOI:10.1002/(SICI)1521-1878(199811)20:11<955:AID-BIES11>3.0.CO;2-8.
    [22] SCIAMANNA I, VITULLO P, CURATOLO A, et al. Retrotransposons, reverse transcriptase and the genesis of new genetic information[J]. Gene, 2009, 448( 2): 180- 186. DOI: 10.1016/j.gene.2009.07.011.
    [23] PITTOGGI C, BERALDI R, SCIAMANNA I, et al. Generation of biologically active retro-genes upon interaction of mouse spermatozoa with exogenous DNA[J]. Mol Reprod Dev, 2006, 73( 10): 1239- 1246. DOI: 10.1002/mrd.20550.
    [24] BA ALI, HUANG TH, XIE QD. Detection and expression of hepatitis B virus X gene in one and two-cell embryos from golden Hamster oocytes in vitro fertilized with human spermatozoa carrying HBV DNA[J]. Mol Reprod Dev, 2005, 70( 1): 30- 36. DOI: 10.1002/mrd.20185.
    [25] ZHANG LY, FANG ZX, ZHENG Z, et al. Prelminary research on the paternal-fetal transmission of hepatitis b virus[J]. Chin J Infect Dis, 1994, 12( 4): 199- 201.

    张丽云, 方之勋, 郑兆, 等. 乙型肝炎病毒父婴传播途径的初步研究[J]. 中华传染病杂志, 1994, 12( 4): 199- 201.
    [26] YE F, YUE YF, LI SH, et al. Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infection[J]. Am J Obstet Gynecol, 2006, 194( 2): 387- 392. DOI: 10.1016/j.ajog.2005.07.011.
    [27] NIE R, JIN L, ZHANG HW, et al. Presence of hepatitis B virus in oocytes and embryos: A risk of hepatitis B virus transmission during in vitro fertilization[J]. Fertil Steril, 2011, 95( 5): 1667- 1671. DOI: 10.1016/j.fertnstert.2010.12.043.
    [28] KONG Y, LIU Y, LIU XJ, et al. Relationship between the mechanism of hepatitis B virus father-infant transmission and pregnancy outcome[J]. Arch Gynecol Obstet, 2017, 295( 1): 253- 257. DOI: 10.1007/s00404-016-4231-6.
    [29] HUANG JM, HUANG TH, QIU HY, et al. Studies on the integration of hepatitis B virus DNA sequence in human sperm chromosomes[J]. Asian J Androl, 2002, 4( 3): 209- 212.
    [30] YI W, LI MH, SUN FF, et al. Impact of in vitro fertilization-embryo transfer on mother-to-infant transmission in women with chronic HBV infection[J]. Liver Int, 2022, 42( 10): 2167- 2174. DOI: 10.1111/liv.15349.
    [31] NIE R, WANG MY, LIAO TT, et al. Assisted conception does not increase the risk for mother-to-child transmission of hepatitis B virus, compared with natural conception: A prospective cohort study[J]. Fertil Steril, 2019, 111( 2): 348- 356. DOI: 10.1016/j.fertnstert.2018.10.021.
  • 加载中
计量
  • 文章访问数:  96
  • HTML全文浏览量:  22
  • PDF下载量:  37
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-09-03
  • 录用日期:  2024-10-04
  • 出版日期:  2024-11-25
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回